Nature Communications (Jan 2018)

A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients

  • Jean-Louis Guéant,
  • Céline Chéry,
  • Abderrahim Oussalah,
  • Javad Nadaf,
  • David Coelho,
  • Thomas Josse,
  • Justine Flayac,
  • Aurélie Robert,
  • Isabelle Koscinski,
  • Isabelle Gastin,
  • Pierre Filhine-Tresarrieu,
  • Mihaela Pupavac,
  • Alison Brebner,
  • David Watkins,
  • Tomi Pastinen,
  • Alexandre Montpetit,
  • Fadi Hariri,
  • David Tregouët,
  • Benjamin A Raby,
  • Wendy K. Chung,
  • Pierre-Emmanuel Morange,
  • D. Sean Froese,
  • Matthias R. Baumgartner,
  • Jean-François Benoist,
  • Can Ficicioglu,
  • Virginie Marchand,
  • Yuri Motorin,
  • Chrystèle Bonnemains,
  • François Feillet,
  • Jacek Majewski,
  • David S. Rosenblatt

DOI
https://doi.org/10.1038/s41467-017-02306-5
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 12

Abstract

Read online

Inborn errors of vitamin B12 metabolism of the cblC class are caused by mutations in the MMACHC gene. Here, Guéant et al. report epi-cblC, a class of cblC in which patients are compound heterozygous for a genetic mutation and a secondary epimutation at the MMACHC locus.